Investor Presentaiton

Our technology, combined with a patient preferred modality, allows for a scalable business GUARDANT™ 2 INVESTOR 20 DAY 23 1 High performance in detecting early- stage cancer Positive unit economics to scale shield™ Broad reimbursement & access Patient preference 3 4 118

View entire presentation